Researchers have found in a new study that patients of cannabis dependence have worse outcomes in Asthma exacerbations.The research was presented at the CHEST Annual Meeting 2020 held virtually due to COVID-19.Recent changes in the legalization of recreational cannabis have increased its use by public at large but simultaneously has led to growing concerns about its safety and public...
Researchers have found in a new study that patients of cannabis dependence have worse outcomes in Asthma exacerbations.The research was presented at the CHEST Annual Meeting 2020 held virtually due to COVID-19.
Recent changes in the legalization of recreational cannabis have increased its use by public at large but simultaneously has led to growing concerns about its safety and public health implications.
Cannabis use may have the risk of future respiratory complications in Asthma patients but till date, there has been no study examining the relationship between cannabis dependence (CD) and hospital admissions for asthma exacerbations (AE).
The present study was conducted solely aimed to examine the relationship between cannabis dependence and asthma exacerbations using the National Readmission Database.
"We found that cannabis use is related to higher in-hospital mortality, higher morbidity including higher IR, use PIMV, and Resource utilization, including total Hospitalization Cost with No Difference in 30 Day-readmission, BR and LOS", exclaimed Palakkumar Patel, the lead author of the study.
A retrospective analysis of 179,771 patients narrowed down from the 2016 and 2017 National Readmission Database was carried out. Admissions with a diagnosis of Asthma Exacerbation (AE) as primary diagnosis and cannabis dependence as a secondary diagnosis using ICD 10-CM codes was highlighted as the inclusion criteria. However, patients under 18 years, non-elective admission, and discharged prior were excluded.
The primary outcome was in-hospital mortality during the index admission. Secondary outcomes were 30-Day Readmission rates, Resource utilization, and Morbidity Including Intubation rates (IR), Prolong Invasive Mechanical Ventilation >96hr (PIMV), and Bronchoscopy rate (BR) during the Index admission. We used multivariate linear/logistic models to adjust for confounders, describes Patel and colleagues.
Of the total shortlisted sample, only 6,583 (3.67 %) patients had a diagnosis of CD. CD was most commonly seen in patients with a mean age of 35 years and more so among the males (51.5%).
The following findings were noted-
a. CD was associated with higher morbidity including Intubation rates, Prolong Invasive Mechanical Ventilation.
b. CD was also associated with higher resource utilization with total hospitalization cost.
c. Both patient groups have similar odds of 30-day readmission, and Bronchoscopy rates and length of stay.
"As the legalization of recreational cannabis use continues to gain popularity, clinicians and legislators need to consider the above implications of cannabis use," the researchers wrote. "Future studies should evaluate the exact mechanism of increased mortality and morbidity linked to cannabis dependence."said authors.
For further reference log on to:
Patel P, Arjun S, Wang Y, Li S, Patel P. Impact of cannabis dependence in patients admitted with asthma exacerbation on their healthcare outcomes and readmission: a US population cohort study. Presented at: the CHEST Virtual Annual Meeting; October 18-21, 2020. Abstract 24.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd